LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
LMFA01140109
|
Tripmycin A
|
13-(2-methylphenyl)-12E-tridecenoic acid
|
FA 20:5
|
C20H30O2
|
302.224580
|
LMFA01140110
|
|
5-(2-Methylphenyl)-4-pentenoic acid
|
FA 12:5
|
C12H14O2
|
190.099380
|
LMFA01140110
|
|
5-(2-Methylphenyl)-4-pentenoic acid
|
FA 12:5
|
C12H14O2
|
190.099380
|
LMFA01031361
|
Menzeleic acid
|
6Z,13Z-hexadecadienoic acid
|
FA 16:2
|
C16H28O2
|
252.208930
|
LMFA03010151
|
PGE2-EA
|
N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
LMFA03010151
|
PGE2-EA
|
N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
LMFA03010151
|
PGE2-EA
|
N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
LMFA01050604
|
22-HDHA
|
22-hydroxy-4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid
|
FA 22:6;O
|
C22H32O3
|
344.235145
|
LMFA01050604
|
22-HDHA
|
22-hydroxy-4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid
|
FA 22:6;O
|
C22H32O3
|
344.235145
|
LMFA07070120
|
3S,7Z-hydroxytetradecenoylcarnitine
|
3-{[(7Z)-3-hydroxytetradec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
LMFA07070120
|
3S,7Z-hydroxytetradecenoylcarnitine
|
3-{[(7Z)-3-hydroxytetradec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
LMFA07070123
|
2E,7Z-tetradecadienoylcarnitine
|
3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
LMFA07070123
|
2E,7Z-tetradecadienoylcarnitine
|
3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
LMFA07070124
|
2E,5Z-dodecadienoylcarnitine
|
3-[(2E,5Z)-dodeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 12:2
|
C19H33NO4
|
339.240959
|
LMFA07070124
|
2E,5Z-dodecadienoylcarnitine
|
3-[(2E,5Z)-dodeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 12:2
|
C19H33NO4
|
339.240959
|
LMFA07070126
|
7Z-Hexadecenoylcarnitine
|
3-[(7Z)-hexadeca-7-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:1
|
C23H43NO4
|
397.319209
|
LMFA07070126
|
7Z-Hexadecenoylcarnitine
|
3-[(7Z)-hexadeca-7-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:1
|
C23H43NO4
|
397.319209
|
LMFA07070128
|
(7Z)-3S-hydroxyhexadecenoylcarnitine
|
3S-{[(7Z)-3-hydroxyhexadec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:1;O
|
C23H43NO5
|
413.314124
|
LMFA07070128
|
(7Z)-3S-hydroxyhexadecenoylcarnitine
|
3S-{[(7Z)-3-hydroxyhexadec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:1;O
|
C23H43NO5
|
413.314124
|
LMFA07070129
|
(5Z)-3S-hydroxytetradecenoylcarnitine
|
3S-{[(5Z)-3-hydroxytetradec-5-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
LMFA07070129
|
(5Z)-3S-hydroxytetradecenoylcarnitine
|
3S-{[(5Z)-3-hydroxytetradec-5-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
LMFA07070130
|
2E,5Z-tetradecadienoylcarnitine
|
3-[(2E,5Z)-tetradeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
LMFA07070130
|
2E,5Z-tetradecadienoylcarnitine
|
3-[(2E,5Z)-tetradeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
LMFA07070134
|
2E,decenoylcarnitine
|
3-[(2E-decenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 10:1
|
C17H31NO4
|
313.225309
|
LMFA07070134
|
2E,decenoylcarnitine
|
3-[(2E-decenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 10:1
|
C17H31NO4
|
313.225309
|
LMFA07070131
|
3S-hydroxyhexadecanoylcarnitine
|
3S-{[-3-hydroxyhexadecanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:0;O
|
C23H45NO5
|
415.329774
|
LMFA07070131
|
3S-hydroxyhexadecanoylcarnitine
|
3S-{[-3-hydroxyhexadecanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:0;O
|
C23H45NO5
|
415.329774
|
LMFA01050605
|
10-hydroxypalmitic acid
|
10-hydroxyhexadecanoic acid
|
FA 16:0;O
|
C16H32O3
|
272.235145
|
LMFA03050032
|
11,12,15-THETA
|
11,12,15-trihydroxy-5Z,8Z,13E-eicosatrienoic acid
|
FA 20:3;O3
|
C20H34O5
|
354.240625
|
LMFA03050032
|
11,12,15-THETA
|
11,12,15-trihydroxy-5Z,8Z,13E-eicosatrienoic acid
|
FA 20:3;O3
|
C20H34O5
|
354.240625
|
LMFA02030075
|
Callicarboric acid A
|
Methyl (1R,2R)-4-oxo-5-(2-oxo-3E-pentenyl)-2-cyclopentene-1-octanoate
|
FA 19:5;O2
|
C19H28O4
|
320.198760
|
LMFA02030075
|
Callicarboric acid A
|
Methyl (1R,2R)-4-oxo-5-(2-oxo-3E-pentenyl)-2-cyclopentene-1-octanoate
|
FA 19:5;O2
|
C19H28O4
|
320.198760
|
LMFA02030075
|
Callicarboric acid A
|
Methyl (1R,2R)-4-oxo-5-(2-oxo-3E-pentenyl)-2-cyclopentene-1-octanoate
|
FA 19:5;O2
|
C19H28O4
|
320.198760
|
LMFA02030076
|
Callicarboric acid B
|
Methyl (1S,2R)-4-oxo-5-(methyl acetoyl)-2-cyclopentene-1-octanoate
|
FA 17:4;O3
|
C17H26O5
|
310.178025
|
LMFA02030076
|
Callicarboric acid B
|
Methyl (1S,2R)-4-oxo-5-(methyl acetoyl)-2-cyclopentene-1-octanoate
|
FA 17:4;O3
|
C17H26O5
|
310.178025
|
LMFA02030076
|
Callicarboric acid B
|
Methyl (1S,2R)-4-oxo-5-(methyl acetoyl)-2-cyclopentene-1-octanoate
|
FA 17:4;O3
|
C17H26O5
|
310.178025
|
LMFA02030076
|
Callicarboric acid B
|
Methyl (1S,2R)-4-oxo-5-(methyl acetoyl)-2-cyclopentene-1-octanoate
|
FA 17:4;O3
|
C17H26O5
|
310.178025
|
LMFA01020445
|
|
(Z)-13-Methyltetradec-4-enoic acid
|
FA 15:1
|
C15H28O2
|
240.208930
|
LMFA01020445
|
|
(Z)-13-Methyltetradec-4-enoic acid
|
FA 15:1
|
C15H28O2
|
240.208930
|
LMFA01060244
|
17Z-Insignoic acid A
|
6-hydroxy-4-oxotetracosa-2E,17Z-dienoic acid
|
FA 24:3;O2
|
C24H42O4
|
394.308310
|
LMFA01060244
|
17Z-Insignoic acid A
|
6-hydroxy-4-oxotetracosa-2E,17Z-dienoic acid
|
FA 24:3;O2
|
C24H42O4
|
394.308310
|
LMFA01060244
|
17Z-Insignoic acid A
|
6-hydroxy-4-oxotetracosa-2E,17Z-dienoic acid
|
FA 24:3;O2
|
C24H42O4
|
394.308310
|
LMFA01060247
|
17Z-Insignoic acid B
|
4-oxotetracosa-2E,5E,17Z-trienoic acid
|
FA 24:4;O
|
C24H40O3
|
376.297745
|
LMFA01060247
|
17Z-Insignoic acid B
|
4-oxotetracosa-2E,5E,17Z-trienoic acid
|
FA 24:4;O
|
C24H40O3
|
376.297745
|
LMFA01060248
|
18Z-Insignoic acid B
|
4-oxotetracosa-2E,5E,18Z-trienoic acid
|
FA 24:4;O
|
C24H40O3
|
376.297745
|
LMFA01060248
|
18Z-Insignoic acid B
|
4-oxotetracosa-2E,5E,18Z-trienoic acid
|
FA 24:4;O
|
C24H40O3
|
376.297745
|
LMFA01060250
|
21Z-Insignoic acid B
|
4-oxotetracosa-2E,5E,21Z-trienoic acid
|
FA 24:4;O
|
C24H40O3
|
376.297745
|
LMFA01060250
|
21Z-Insignoic acid B
|
4-oxotetracosa-2E,5E,21Z-trienoic acid
|
FA 24:4;O
|
C24H40O3
|
376.297745
|
LMFA01060253
|
17Z-Insignoic acid C
|
6-ethoxy-4-oxotetracosa-2E,17Z-dienoic acid
|
FA 26:3;O2
|
C26H46O4
|
422.339610
|
LMFA01060253
|
17Z-Insignoic acid C
|
6-ethoxy-4-oxotetracosa-2E,17Z-dienoic acid
|
FA 26:3;O2
|
C26H46O4
|
422.339610
|